The main aim of our research was development of a novel selective electrochemical method for imipramine (IMI) detection. This substance enable to interact with DNA and it is also electrochemically active. Two major groups of electrochemical sensors were used in the experiments with bare gold electrodes and DNA-modified. Determination of imipramine by means of non-modified electrodes was not selective and limit of detection was shifted towards higher concentrations of IMI. The sensitivity of mixed and mono-GC sequence DNA-modified electrodes was much higher than for the bare gold ones.
Introduction
The DNA biosensors provide fast, simple, sensitive and selective detection of target substance through its interaction with double-stranded DNA immobilized on the active sensors surface. Imipramine (IMI) is a tricyclic antidepressant (TCA), which belongs to the dibenzazepine group. Due to side-effects for depressive patients treated using these drugs, which may be toxicity and/or inability to drive mechanical vehicles [1] , their determination is important in clinical diagnostics. There are a few reports related to electrochemical IMI detection including utilization of highly boron-doped diamond electrodes [1] , functionalized carbon paste electrodes [2] and indium-tin oxide (ITO) electrodes modified with molecularly imprinted polymer (MIP) and Au-nanoparticles [3] . 
Nomenclature

Experimental
Chemicals
The 21-mer modified (at 3'-end) oligonucleotide HS-(CH 2 ) 3 -3'-AAG GCC GAC TCA GTA GTT CGC-5' and complementary strand 5'-TTC CGG CTG AGT CAT CAA GCG-3' were synthesized by Oligo.pl (Warsaw, Poland). The 21-mer modified (at 3'-end) oligonucleotides HS-(CH 2 ) 3 -3'-(A) 21 -5' and HS-(CH 2 ) 3 -3'-(G) 21 -5' and respectively complementary strands 5'-(T) 21 -3', 5'-(C) 21 -3' were synthesized by Genomed. Acetaminophen, L-ascorbic acid, imipramine and 6-mercapto-1-hexanol were obtained from Sigma-Aldrich. Chlorpromazine was obtained from MP Biomedicals, LLC. Analytical grade reagents and purified water from Millipore Milli-Q system were used for the preparation of phosphate buffer solution.
Sensors fabrication and measurements
In experiments, gold paste electrochemical sensors manufactured by microdosing robot, fabricated in our laboratory [4] , were modified with the use of short thiol-labeled oligonucleotides HS-(CH 2 ) 3 -3'-AAG GCC GAC TCA GTA GTT CGC-5' and complementary strands 5'-TTC CGG CTG AGT CAT CAA GCG-3' forming mixed sequence DNA. After immobilization of thiol-labeled strands, extant free surface was blocked by means of 6-mercapto-1-hexanol. Then hybridization with complementary strand was performed at room temperature for 1 h. For elimination of non-specific binding of DNA strands, after each step the electrodes were vigorously rinsed with MQ water. The biosensors prepared according to the described procedure were incubated in solutions of imipramine at concentration range from 0.0005 to 50.0 μM for 2 min, afterwards electrodes were rinsed.
In the next stage of experiments sensors were modified (according to above-described procedure) with use one of the short thiol-labeled oligonucleotides HS-(CH 2 ) 3 -3'-(A) 21 -5' or HS-(CH 2 ) 3 -3'-(G) 21 -5' then hybridized with complementary strands 5'-(T) 21 -3' and 5'-(C) 21 -3', to form mono-AT, and mono-GC sequence DNA, respectively. Prepared biosensors were incubated in solutions of imipramine at concentration range from 0.005 to 0.1 μM for 2 min, next electrodes were rinsed.
Afterwards electrochemical measurements were performed in 0.17 M phosphate buffer solution (pH 7.5), by differential pulse voltammetry (DPV) with the use of PalmSens potentiostat (Palm Instruments BV, The Netherlands). For comparison the same procedure was applied for measurements of imipramine with use of bare gold electrodes and DNA modified ones.
The last stage of experiments were measurements in sample containing 400 nM IMI, 50 μM CPZ, 200 μM PCT and 2000 μM AA with the use of two measuring methods DPV and linear sweep voltammetry (LSV).
Results
Comparison of the performances of the electrochemical sensors for imipramine with bare gold electrodes and DNA modified ones are shown in Fig. 1a and Fig. 1b . Linear concentration range of imipramine determination by means of DNA-modified electrodes is significantly shifted towards lower concentrations. In this case of DNAmodified biosensors low detection limit is c.a. 0.0005 μM, while for sensors with bare gold electrodes -c.a. 1 μM. As it can be seen in Fig. 2 . the best results (the highest oxidation peaks) and lower standard deviation values were obtained for Au electrodes modified with mixed sequence DNA, while Au modification with mono-GC sequence DNA effects in lower imipramine oxidation peaks and higher standard deviation values. For Au modification with mono-AT sequence DNA imipramine oxidation peaks do not occur. In the case of non-modified electrodes, determination of imipramine was not selective and shifted towards high concentration range (Fig. 3) . The resulting sensitivity of DNA-modified electrodes was much higher than for the bare gold electrodes. For the above mentioned three group of sensors -1) bare gold electrodes measured in imipramine solutions, 2) bare gold electrodes measured in phosphate buffer solution after 2-minute incubation and 3) mixed sequence DNA-modified electrodes, imipramine linear concentration ranges are as follows: 10.0 -50.0 μM, 2.0 -30.0μM, 0.005 -0.05 μM, respectively.
As it can be seen in Fig. 4 , in the case of DPV method both peaks corresponding with peak potentials chlorpromazine (c.a. +0.55V) and imipramine (c.a. +0.74 V) are visible. Using LSV method only one, chlorpromazine oxidation peak (c.a. +0.66 V) is visible, what corresponds with results obtained previously described in paper [5] . Summarizing, determination of imipramine by means of non-modified electrodes was not selective and limit of detection was shifted towards higher concentrations of imipramine. The sensitivity of mixed and mono-GC sequence DNA-modified electrodes was much higher than for the bare gold ones.
